Gwo Xi Stem Cell Applied Technology Co. , Ltd (TPEX:6704)
Taiwan
· Delayed Price · Currency is TWD 22.00
-0.15 (-0.68%)
May 21, 2025, 1:22 PM CST
TPEX:6704 Revenue
In the year 2024, Gwo Xi Stem Cell Applied Technology Co. , had annual revenue of 170.03M TWD with 20.44% growth. Gwo Xi Stem Cell Applied Technology Co. , had revenue of 90.42M in the half year ending December 31, 2024, with 0.27% growth.
Revenue
170.03M
Revenue Growth
+20.44%
P/S Ratio
12.50
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.13B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 170.03M | 28.85M | 20.44% |
| Dec 31, 2023 | 141.18M | -39.49M | -21.86% |
| Dec 31, 2022 | 180.67M | -62.09M | -25.58% |
| Dec 31, 2021 | 242.75M | 54.21M | 28.75% |
| Dec 31, 2020 | 188.54M | 11.86M | 6.71% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2013 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| PharmaEssentia | 11.34B |
| Caliway Biopharmaceuticals | 40.47M |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Polaris Group | 87.67M |
| Oneness Biotech | 117.33M |
| Pegavision | 6.69B |
| Center Laboratories | 1.63B |